Heng Sun

1.6k total citations · 1 hit paper
25 papers, 740 citations indexed

About

Heng Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Heng Sun has authored 25 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Heng Sun's work include Cancer Genomics and Diagnostics (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Mechanisms and Therapy (3 papers). Heng Sun is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Mechanisms and Therapy (3 papers). Heng Sun collaborates with scholars based in China, Macao and United States. Heng Sun's co-authors include Chu‐Xia Deng, Kai Miao, Aiping Zhang, Fangyuan Shao, Xiaoling Xu, Xingquan Xu, Zhiguang Sun, Dongquan Shi, Hui Wei and Jianhua Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nano Letters.

In The Last Decade

Heng Sun

23 papers receiving 731 citations

Hit Papers

Tumor heterogeneity reshapes the tumor microenvironment t... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
    2022 184 citations Aiping Zhang, Kai Miao et al. International Journal of Biological Sciences profile →

Peers

Heng Sun
Jiaxin Yang China
Jianpeng Sheng China
Haidong Gao China
Kuansong Wang China
Baofeng Guo China
Haoyu Wang China
Xiaoguang Yu China
Yujia Guo China
Zhiyu Li China
Qing Shi China
Jiaxin Yang China
Heng Sun
Citations per year, relative to Heng Sun Heng Sun (= 1×) peers Jiaxin Yang

Countries citing papers authored by Heng Sun

Since Specialization
Citations

This map shows the geographic impact of Heng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Sun more than expected).

Fields of papers citing papers by Heng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Sun. The network helps show where Heng Sun may publish in the future.

Co-authorship network of co-authors of Heng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Sun. A scholar is included among the top collaborators of Heng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Sun. Heng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qi‐Chao, Heng Sun, & Zhi‐Jun Sun. (2025). Targeting oncogenic signal pathway to improve cancer immunotherapy: Insights and perspectives. Biochemical Pharmacology. 239. 117043–117043.
2.
Miao, Kai, Aiping Zhang, Xiaodan Yang, et al.. (2025). Lymphatic system is the mainstream for breast cancer dissemination and metastasis revealed by single-cell lineage tracing. Molecular Cancer. 24(1). 75–75. 2 indexed citations
3.
4.
Tang, Dongyang, Shiqi Lin, Jingbo Zhou, et al.. (2025). Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer. Cell Reports Medicine. 6(7). 102211–102211. 1 indexed citations
5.
Sun, Heng, et al.. (2024). Molecular-Scale Investigations Reveal the Effect of Natural Polyphenols on BAX/Bcl-2 Interactions. International Journal of Molecular Sciences. 25(5). 2474–2474. 4 indexed citations
6.
Shao, Fangyuan, Jianming Zeng, Sen Guo, et al.. (2023). Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science Advances. 9(3). eabq1395–eabq1395. 10 indexed citations
7.
Yang, Ziyi, Heng Sun, Chen Huang, et al.. (2023). Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma. Clinical Cancer Research. 29(19). 3986–4001. 6 indexed citations
8.
Zhou, Jingbo, Dongyang Tang, Shiqi Lin, et al.. (2023). Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation. Pharmacological Research. 194. 106830–106830. 31 indexed citations
9.
Zhang, Aiping, Kai Miao, Heng Sun, & Chu‐Xia Deng. (2022). Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. International Journal of Biological Sciences. 18(7). 3019–3033. 184 indexed citations breakdown →
10.
Guo, Qi, et al.. (2022). MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro. Biochemical and Biophysical Research Communications. 632. 48–54. 4 indexed citations
11.
Wang, Xishu, et al.. (2021). Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 601668–601668. 23 indexed citations
12.
Quan, Yingyao, Jianming Zeng, Xueying Lyu, et al.. (2021). Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice. International Journal of Biological Sciences. 17(15). 4176–4191. 14 indexed citations
13.
Sun, Heng, Xiaoling Xu, & Chu‐Xia Deng. (2020). Preparation of Single Epithelial Cells Suspension from Mouse Mammary Glands. BIO-PROTOCOL. 10(4). e3530–e3530. 2 indexed citations
14.
Miao, Kai, Sek Man Su, Lihua Mo, et al.. (2020). Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor. Nature Communications. 11(1). 4875–4875. 19 indexed citations
15.
Yu, Lin, et al.. (2020). Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma. Journal of Immunotherapy. 44(3). 106–113. 14 indexed citations
16.
Lin, Yu, Xi Yang, Heng Sun, et al.. (2020). Generation of fully human anti-GPC3 antibodies with high-affinity recognition of GPC3 positive tumors. Investigational New Drugs. 39(3). 615–626. 4 indexed citations
17.
Sun, Heng, Zhengqiang Miao, Xin Zhang, et al.. (2018). Single-cell RNA-Seq reveals cell heterogeneity and hierarchy within mouse mammary epithelia. Journal of Biological Chemistry. 293(22). 8315–8329. 32 indexed citations
18.
Wong, Ada Hang‐Heng, Haoran Li, Yanwei Jia, et al.. (2017). Drug screening of cancer cell lines and human primary tumors using droplet microfluidics. Scientific Reports. 7(1). 9109–9109. 75 indexed citations
19.
Chen, Si, Heng Sun, Kai Miao, & Chu‐Xia Deng. (2016). CRISPR-Cas9: from Genome Editing to Cancer Research. International Journal of Biological Sciences. 12(12). 1427–1436. 31 indexed citations
20.
Chen, Ying, Guo‐Hua Fong, Qiulei Xi, et al.. (2015). PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function. Journal of Biological Chemistry. 290(33). 20580–20589. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiaxin Yang Breakdown of academic impact, for papers by Jianpeng Sheng Breakdown of academic impact, for papers by Haidong Gao Breakdown of academic impact, for papers by Kuansong Wang Breakdown of academic impact, for papers by Baofeng Guo Breakdown of academic impact, for papers by Haoyu Wang Breakdown of academic impact, for papers by Xiaoguang Yu Breakdown of academic impact, for papers by Yujia Guo Breakdown of academic impact, for papers by Zhiyu Li Breakdown of academic impact, for papers by Qing Shi
Rankless by CCL
2026